Comment on: How to use bisphosphonates safely and optimally.
暂无分享,去创建一个
[1] K. Saag,et al. How to use bisphosphonates safely and optimally. , 2018, Rheumatology.
[2] R. Barron,et al. Medication persistence and risk of fracture among female Medicare beneficiaries diagnosed with osteoporosis , 2018, Osteoporosis International.
[3] M. Intorcia,et al. Persistence with denosumab and persistence with oral bisphosphonates for the treatment of postmenopausal osteoporosis: a retrospective, observational study, and a meta-analysis , 2015, Osteoporosis International.
[4] C. McHorney,et al. Medication nonfulfillment rates and reasons: narrative systematic review , 2010, Current medical research and opinion.
[5] S. Cummings,et al. Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. , 2007, The New England journal of medicine.
[6] M. Ettinger,et al. Improving compliance and persistence with bisphosphonate therapy for osteoporosis. , 2006, The American journal of medicine.